+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Cancer Biologics Market 2025-2029 - Product Thumbnail Image

Cancer Biologics Market 2025-2029

  • Report
  • March 2025
  • 243 Pages
  • Global
From
From
Anti-Lymphotoxin - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Lymphotoxin - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Encephalitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Encephalitis Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 478 Pages
  • Global
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
Oncology Pharmaceuticals Market - Product Thumbnail Image

Oncology Pharmaceuticals Market

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Candidiasis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Candidiasis Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 474 Pages
  • Global
From
From
Anaphylaxis Treatment Market Report 2025 - Product Thumbnail Image

Anaphylaxis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
TNF Inhibitors - Global Strategic Business Report - Product Thumbnail Image

TNF Inhibitors - Global Strategic Business Report

  • Report
  • July 2025
  • 191 Pages
  • Global
From
Loading Indicator